Skip to main content

. 1967 Jul;15(4):940–942. doi: 10.1128/am.15.4.940-942.1967

Effect of beta-propiolactone on adventitious viruses in mouse immune ascitic fluids and sera.

A M Behbehani, J K McMillen, M S Hiller, H A Wenner

PMCID: PMC547101 PMID: 6049310

940

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

HERRMANN E. C., Jr, ENGLE C. Tumor cell-induced mouse ascites fluid as a source of viral antibodies. Proc Soc Exp Biol Med. 1958 Jun;98(2):257–259. doi: 10.3181/00379727-98-24009. [DOI] [PubMed] [Google Scholar]
POLLEY J. R., GUERIN M. M. The use of beta-propiolactone for the preparation of virus vaccines. I. Selection of reaction conditions. Can J Microbiol. 1957 Oct;3(6):863–870. doi: 10.1139/m57-095. [DOI] [PubMed] [Google Scholar]
SEVER J. L., CASTELLANO G. A., PELON W., HUEBNER R. J., WOLMAN F. INACTIVATION OF THE INFECTIVITY OF VIRAL HEMAGGLUTINATING ANTIGENS WITH THE USE OF BETAPRONE. J Lab Clin Med. 1964 Dec;64:983–988. [PubMed] [Google Scholar]
Tikasingh E. S., Spence L., Downs W. G. The use of adjuvant and sarcoma 180 cells in the production of mouse hyperimmune ascitic fluids to arboviruses. Am J Trop Med Hyg. 1966 Mar;15(2):219–226. doi: 10.4269/ajtmh.1966.15.219. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES